Lung Cancer Research, 739 Zeigler Research Building, 703 19th Street South, Birmingham, AL 35294-0007, USA.
Thorac Surg Clin. 2014 May;24(2):151-6, v. doi: 10.1016/j.thorsurg.2014.02.006.
Robotic surgery is safe and efficient, with similar survival rates to the open and video-assisted thoracoscopic surgery (VATS) approaches. The surgeon can provide an R0 resection in patients with cancer. Technical modifications lead to decreased operative times and may improve the ability to teach. The capital cost, service contract costs, and equipment costs have to be carefully considered and studied, and patient selection is critical. There are few achievable benefits of using a robotic system compared with VATS when performing a sympathotomy for patients with hyperhidrosis or a pulmonary wedge resection for tissue diagnosis for patients with interstitial lung disease.
机器人手术安全有效，其生存率与开胸手术和电视辅助胸腔镜手术（VATS）相似。外科医生可以为癌症患者提供 R0 切除术。技术改进可减少手术时间，并可能提高教学能力。资本成本、服务合同成本和设备成本需要仔细考虑和研究，患者选择至关重要。与 VATS 相比，在为多汗症患者行交感神经切断术或为间质性肺病患者行肺楔形切除术进行组织诊断时，使用机器人系统的获益有限。
